Skip to main content
. 2023 Apr 16;6(4):e1213. doi: 10.1002/hsr2.1213

Table 1.

Demographic and clinical data.

Metadata Participants, n = 449
Sex (n, %)
Male 279 (62)
Female 170 (38)
Age group (years) (n, %)
<5 1 (0.2)
5–17 26 (5.8)
18–30 125 (27.8)
31–40 100 (22.3)
41–50 62 (13.8)
51–60 56 (12.5)
>60 79 (17.6)
Agea 41.19 ± 18.25
Clinical features
Fever (n, %) 173 (38.5)
Cough (n, %) 310 (66)
Runny nose (n, %) 282 (62.8)
Sore throat (n, %) 73 (16.3)
Shortness of breath (n, %) 75 (16.7)
Chills (n, %) 16 (3.6)
Vomiting (n, %) 35 (7.8)
Nausea (n, %) 37 (8.2)
Diarrhea (n, %) 20 (4.5)
Altered smell (n, %) 27 (6)
Headache (n, %) 177 (39.42)
Conjunctivitis (n, %) 4 (0.9)
Muscle aches (n, %) 105 (23.4)
Joint aches (n, %) 58 (12.9)
Loss of appetite (n, %) 96 (21.4)
Altered consciousness (n, %) 3 (0.7)
Onset of symptoms
0–3 days 83 (18.5)
4–7 days 180 (40.1)
>7 days 168 (37.4)
No symptoms 18 (4.0)
Hospitalization
Yes 230 (70)
No 219 (30)
Comorbidities (n, %)
Yes 124 (27.6)
No 325 (62.4)
Body temperature (⁰C)a 36.39 ± 0.58
Respiratory rate (/minutes)a 19.49 ± 1.76
Pulse rate (/minutes)a 82.25 ± 9.88
Systolic blood pressure (mm/Hg)a 115.45 ± 11.11
Diastolic blood pressure (mm/Hg)a 75.88 ± 8.10
Oxygen saturation (%)a 98.10 ± 1.23

Note: Comorbidity includes obesity, cancer, diabetes, asthma, heart diseases, lung diseases (nonasthma), liver diseases, kidney diseases.

Abbreviation: n, study participant.

a

Results presented as mean ± SD.